Other Head and Neck Sites
There is minimal to no data regarding the use of SBRT as definitive primary treatment in other head & neck disease sites. Limited data support the use of brachytherapy or SBRT as a boost to EBRT in the definitive setting for nasopharyngeal (Chap. 1), paranasal sinus, and oropharyngeal SCC.
Generally indicated for T1-2 tumors.
Efficacy and complication rates are similar between brachytherapy and SBRT.
KeywordsHead and neck SBRT Treatment boost
© Springer International Publishing AG, part of Springer Nature 2018